Скачать или смотреть One big question with Charles Craddock: what AML advance could transform frontline care in 3 years?

One big question with Charles Craddock: what AML advance could transform frontline care in 3 years?

Speaker: Charles CraddockInstitution: University of BirminghamEvent: iwAL 2025Format: InterviewSubject: LeukemiaSubject: Acute myeloid leukemiaField: TreatmentField: PerspectivesField: Community focusField: TransplantationMedicines: VenetoclaxMedicines: AzacitidineMedicines: Quizartinib

Скачать One big question with Charles Craddock: what AML advance could transform frontline care in 3 years? бесплатно в качестве 4к (2к / 1080p)

У нас вы можете скачать бесплатно One big question with Charles Craddock: what AML advance could transform frontline care in 3 years? или посмотреть видео с ютуба в максимальном доступном качестве.

Для скачивания выберите вариант из формы ниже:

Информация по загрузке:

Cкачать музыку One big question with Charles Craddock: what AML advance could transform frontline care in 3 years? бесплатно в формате MP3:

Если иконки загрузки не отобразились, ПОЖАЛУЙСТА, НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если у вас возникли трудности с загрузкой, пожалуйста, свяжитесь с нами по контактам, указанным в нижней части страницы.
Спасибо за использование сервиса video2dn.com

Описание к видео One big question with Charles Craddock: what AML advance could transform frontline care in 3 years?

In this special 'One Big Question' segment, Charles Craddock, CBE, FRCP(UK), FRCPath, DPhil, FMedSci, University of Birmingham, Birmingham, UK, shares his perspectives on the most important trial or development poised to transform frontline treatment in acute myeloid leukemia (AML) over the next three years, drawing focus on the increasing adoption of venetoclax-based regimens in patients going to transplant. This interview took place at the 7th International Workshop on Acute Leukemias (iwAL 2025), held in Washington, DC.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Комментарии

Информация по комментариям в разработке